Kalvista Pharmaceuticals Inc (KALV)

Total Costs & Expenses

$255.92M

TTM · Period ending: · USD

KALV logo

KALV Total Costs & Expenses

Latest reported$255.92M
KALV TTM Total Costs & Expenses ($11.71M → $255.92M)
High-resolution chart · PNG

KALV total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Kalvista Pharmaceuticals Inc Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
255,918,500
239,512,000
218,147,000
204,216,000
187,996,000
181,421,000
171,632,000
155,567,000
140,445,000
123,718,000
117,512,000
113,649,000
110,872,000
105,955,000
105,693,000
103,413,000
96,613,000
87,844,000
73,818,000
62,996,000
57,923,000
52,662,000
54,306,000
54,734,000
53,224,000
54,629,000
50,878,000
48,154,000
45,948,000
39,571,000
35,698,000
32,277,000
27,099,000
24,490,000
26,178,000
21,526,000
18,389,000
18,264,000
15,476,000
17,970,000
21,232,000
21,065,000
19,313,000
17,985,000
14,752,000
11,706,000
9,365,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.